Skip to Content

Join the 'Liver Disease' group to help and get support from people like you.

Liver Disease News

FDA Approves Cholbam (cholic acid) for Rare Bile Acid Synthesis Disorders

Posted 17 Mar 2015 by Drugs.com

March 17, 2015 – Today the U.S. Food and Drug Administration approved Cholbam (cholic acid) capsules, the first FDA approved treatment for pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects, and for patients with peroxisomal disorders (including Zellweger spectrum disorders). Patients with these rare, genetic, metabolic conditions exhibit manifestations of liver disease, steatorrhea (presence of fat in the stool) and complications from decreased fat-soluble vitamin absorption. Individuals with these rare disorders lack the enzymes needed to synthesize cholic acid, a primary bile acid normally produced in the liver from cholesterol. The absence of cholic acid in these patients leads to reduced bile flow, accumulation of potentially toxic bile acid intermediates in the liver (cholestasis), and malabsorption of fats and fat-soluble vitamins in ... Read more

Related support groups: Liver Disease, Pediatrics

Ask a Question